| Business Name: |
Kansas City Cancer Ctr-West |
| Address: |
8919 Parallel Parkway, Kansas City, Kansas 66112 |
| Phone Number: |
(913) 788-8883 |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
Kccc West - Kansas City, KS 66112
Kanza Multispecialty Group - Kansas City, KS 66112
Perry Billy MD - Kansas City, KS 66112
Pierre Podrebarac - Kansas City, KS 66112
Johnson Nadine MD - Kansas City, KS 66112
Rodriguiz Hector MD - Kansas City, KS 66112
Lowry Stephen MD - Kansas City, KS 66112
Palmeri Carlos MD - Kansas City, KS 66112
Meurer Michael Md Facs - Kansas City, KS 66112
Caprice M Olomon Md Inc - Kansas City, KS 66112
Mcsweyn Donald J MD - Kansas City, KS 66112
Brigg Michael J MD - Kansas City, KS 66112
Moritz Rick S MD - Kansas City, KS 66112
Lorenzetti Lisa A MD - Kansas City, KS 66112
Outpatient Department - Kansas City, KS 66112
Wyandot Center Inc - Kansas City, KS 66112
Schultz Jon D MD - Kansas City, KS 66112
Oyer Roy K DO - Kansas City, KS 66112
Appelbaum James MD - Kansas City, KS 66112
Best Christopher MD - Kansas City, KS 66112
|
The company Kansas City Cancer Ctr-West provides B2C services in the form of Doctors from its single location in Kansas.
1 to 4 employees work for Kansas City Cancer Ctr-West, and the business now earns $500.000 to $999.999 per annum.
Kansas City Cancer Ctr-West was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Kansas City Cancer Ctr-West, please call with the phone number (913) 788-8883 or visit its single location at 8919 Parallel Parkway in Kansas City, Kansas 66112.
The location of the single location can also be found using the coordinates 39.128583,-94.786386.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.